This topic contains a solution. Click here to go to the answer

Author Question: The client has been ordered treatment with nitrofurantoin. She complains to the nurse of ... (Read 89 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
The client has been ordered treatment with nitrofurantoin. She complains to the nurse of experiencing brownish, discolored urine. The nurse recognizes that this symptom indicates a(n) _____ the medication.
 
  a. expected side effect of
  b. adverse reaction to
  c. life-threatening reaction to
  d. anaphylactic reaction to

Question 2

The client has been ordered treatment with Aralen. The nurse expect to see decreased _____ in the client.
 
  a. serum glucose
  b. potassium
  c. hemoglobin and hematocrit
  d. calcium



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janieazgirl

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

ANS: A
Brownish urine is a side effect of this medication.

Answer to Question 2

ANS: C
The client who is being treated with Aralen will experience a decrease in his hemoglobin and hematocrit.





 

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library